Paper9748331
The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries.
Sauve AA and 3 others. Biochemistry, 1998. Cited by 110 papers, by iCite.
Cite this record
ConductScience Library. The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries. Papers, record 9748331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9748331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine Diphosphate Ribose | Major topic |
| Antigens, CD | Major topic |
| Antigens, Differentiation | Major topic |
| Guanosine Diphosphate Sugars | Major topic |
| NAD+ Nucleosidase | Major topic |
| ADP-ribosyl Cyclase | |
| ADP-ribosyl Cyclase 1 | |
| Binding, Competitive | |
| Catalysis | |
| Cyclic ADP-Ribose | |
| Fluorescence Polarization | |
| Humans | |
| Hydrolysis | |
| Kinetics | |
| Membrane Glycoproteins | |
| Methanol | |
| NAD | |
| Niacinamide | |
| Nicotinamide Mononucleotide | |
| Spectrometry, Fluorescence | |
| Substrate Specificity |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI34342 | NIAID NIH HHS | United States | R01AI034342 | PubMed and NIH | NIH RePORTER |
| GM19335 | NIGMS NIH HHS | United States | PubMed | PubMed |
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42382976 | The evolving landscape of enzymatic technologies for precision synthesis of antibody-drug conjugates. | Antib Ther | 2026 | https://conductscience.org/library/papers/42382976 | PubMed |
| 42156967 | The rise and fall of SARM1 base-exchange inhibitors. | Commun Chem | 2026 | https://conductscience.org/library/papers/42156967 | PubMed |
| 42136641 | Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective. | Front Immunol | 2026 | https://conductscience.org/library/papers/42136641 | PubMed |
| 41540253 | The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. | Nat Metab | 2026 | https://conductscience.org/library/papers/41540253 | PubMed |
| 40604314 | The role of NAD+ metabolism and its modulation of mitochondria in aging and disease. | NPJ Metab Health Dis | 2025 | https://conductscience.org/library/papers/40604314 | PubMed |
| 40273333 | Kinetic Mechanism of the Emergent Anticancer Target, Human ADP-ribosyltransferase 1. | Biochemistry | 2025 | https://conductscience.org/library/papers/40273333 | PubMed |
| 38746669 | CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma. | iScience | 2024 | https://conductscience.org/library/papers/38746669 | PubMed |
| 38399441 | The Role of NAD+ and NAD+-Boosting Therapies in Inflammatory Response by IL-13. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38399441 | PubMed |
| 37307562 | SARM1, an Enzyme Involved in Axon Degeneration, Catalyzes Multiple Activities through a Ternary Complex Mechanism. | Biochemistry | 2023 | https://conductscience.org/library/papers/37307562 | PubMed |
| 37165408 | NAD+ metabolism-based immunoregulation and therapeutic potential. | Cell Biosci | 2023 | https://conductscience.org/library/papers/37165408 | PubMed |
| 35198877 | SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites. | iScience | 2022 | https://conductscience.org/library/papers/35198877 | PubMed |
| 34799586 | BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities. | Nat Commun | 2021 | https://conductscience.org/library/papers/34799586 | PubMed |
| 34559996 | NAD+ flux is maintained in aged mice despite lower tissue concentrations. | Cell Syst | 2021 | https://conductscience.org/library/papers/34559996 | PubMed |
| 33755743 | Enzymology of extracellular NAD metabolism. | Cell Mol Life Sci | 2021 | https://conductscience.org/library/papers/33755743 | PubMed |
| 32903597 | NAD+ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death. | Front Physiol | 2020 | https://conductscience.org/library/papers/32903597 | PubMed |
| 32049506 | Initial Kinetic Characterization of Sterile Alpha and Toll/Interleukin Receptor Motif-Containing Protein 1. | Biochemistry | 2020 | https://conductscience.org/library/papers/32049506 | PubMed |
| 31577933 | NAD+ in Brain Aging and Neurodegenerative Disorders. | Cell Metab | 2019 | https://conductscience.org/library/papers/31577933 | PubMed |
| 31402913 | NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer. | Front Immunol | 2019 | https://conductscience.org/library/papers/31402913 | PubMed |
| 31214171 | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases. | Front Immunol | 2019 | https://conductscience.org/library/papers/31214171 | PubMed |
| 30801823 | Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3-dependent mechanism in male mice. | J Neurosci Res | 2019 | https://conductscience.org/library/papers/30801823 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BST1 | 683 | PubTator's text mining | https://conductscience.org/library/genes/683 | NCBI Gene |
| CD38 | 952 | PubTator's text mining | https://conductscience.org/library/genes/952 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9748331
GET https://conductscience.org/api/papers/v1/9748331/cited_by?page=2